Key result
Drug-eluting balloons are being explored as an alternative to drug-eluting stents in coronary artery disease to address in-stent thrombosis and prolonged dual antiplatelet therapy.
The use of drug eluting stents (DES) majorly reduced in-stent restenosis though preventing not only recoil of the vessel wall and late negative remodelling, but also significantly inhibiting neo-intimal hyperplasia formation. However, concerns about in-stent thrombosis, and the dependency on prolonged dual antiplatelet therapy, and continued restenosis in complex lesion subsets, led to a search for alternative treatment devices that will tackle restenosis rates without the drawbacks associated with DES.2-5 1. University Medical Center Utrecht, department of Interventional Cardiology
No takes yet. Share an insight, caveat, or question.
Belkacemi et al. (2012) conducted a review in Coronary Artery Disease. Drug-eluting Balloons vs. Drug-eluting stents was evaluated. Drug-eluting balloons are being explored as an alternative to drug-eluting stents in coronary artery disease to address in-stent thrombosis and prolonged dual antiplatelet therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: